Lincoln Capital Corp’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,172
| Closed | -$55K | – | 60 |
|
|
2021
Q1 | $55K | Sell |
16,172
-4,990
| -24% | -$17K | 0.03% | 57 |
|
|
2020
Q4 | $59K | Hold |
21,162
| – | – | 0.04% | 54 |
|
|
2020
Q3 | $53K | Buy |
21,162
+5,152
| +32% | +$12.9K | 0.04% | 55 |
|
|
2020
Q2 | $217K | Sell |
16,010
-7,756
| -33% | -$105K | 0.17% | 44 |
|
|
2020
Q1 | $180 | Hold |
23,766
| – | – | 0.08% | 42 |
|
|
2019
Q4 | $150K | Buy |
23,766
+3,250
| +16% | +$20.5K | 0.11% | 48 |
|
|
2019
Q3 | $80K | Buy |
20,516
+243
| +1% | +$948 | 0.07% | 47 |
|
|
2019
Q2 | $98K | Sell |
20,273
-1,435
| -7% | -$6.94K | 0.09% | 47 |
|
|
2019
Q1 | $178K | Hold |
21,708
| – | – | 0.16% | 46 |
|
|
2018
Q4 | $120K | Buy |
+21,708
| New | +$120K | 0.11% | 49 |
|